NCT06881511View on ClinicalTrials.gov

Exploratory Study on the Efficacy of Betaine Hydrochloride in Treating Autoimmune Gastritis

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 3, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions
Autoimmune Gastritis
Interventions
OTHER

No intervention (Control Group)

Patients in this group will receive standard care and undergo regular follow-up and monitoring without any additional treatment.

DIETARY_SUPPLEMENT

Oral betaine hydrochloride (2 capsules, 3 times daily)

Oral betaine hydrochloride (with pepsin). Patients will take 2 capsules (648 mg per capsule) of betaine hydrochloride, 3 times daily with meals.

Trial Locations (1)

310009

RECRUITING

The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER